PharmTech Europe News

Jun 20, 2017
By Pharmaceutical Technology Editors
The European Commission approved Rixathon for use in all indications of its reference medicine, MabThera.
Jun 16, 2017
By Pharmaceutical Technology Editors
The agency’s management board discussed plans for the relocation of EMA at its June 2017 meeting.
Jun 15, 2017
Pharmaceutical Technology
A recent meeting emphasized the need for more guidance and flexibility from regulators, as well as harmonization, standards, and equipment interoperability.
Jun 12, 2017
By Pharmaceutical Technology Editors
The three regulatory agencies have agreed to data requirements for development of new antibiotics.
Jun 09, 2017
By Pharmaceutical Technology Editors
In its June meeting, the agency’s Pharmacovigilance Risk Assessment Committee discussed medicine safety reviews.
Jun 08, 2017
By Pharmaceutical Technology Editors
Germany-based Grünenthal will gain rights to market and sell Zomig (zolmitriptan) outside of Japan. 
Jun 07, 2017
By Pharmaceutical Technology Editors
The United Kingdom’s Center for Process Innovation (CPI) is investing in a new project, Microstar, which seeks to reduce risk for formulators through the development of accelerated screening methods for predictive design.
Jun 06, 2017
By Pharmaceutical Technology Editors
Takeda will build a new production facility at its existing Grange Castle site in Ireland.
Jun 02, 2017
By Pharmaceutical Technology Editors
The agency released guidance for industry regarding the United Kingdom’s withdrawal from the European Union.
Jun 02, 2017
By Pharmaceutical Technology Editors
The agency published an action plan to nurture innovation and drug development by SMEs.
native1_300x100
lorem ipsum